The confirmation of Mark McClellan as CMS administrator remained in doubt, although McClellan, currently commissioner of the Food and Drug Administration, yielded to a demand by Sen. Byron Dorgan (D-N.D.) that he testify before a Senate committee on his opposition to reimporting drugs from Canada. Some lawmakers expressed dissatisfaction with McClellan's testimony this morning and his lack of a plan to assure the safety of drug reimportation. Sen. John McCain (R-Ariz.), who had several testy exchanges with McClellan during the hearing, said that he would have to think about whether to vote to approve McClellan's nomination in the full Senate. Dorgan said McClellan's previous unwillingness to testify on drug reimportation indicated he might not work cooperatively with Congress on several matters. Meanwhile, following criticism, HHS Secretary Tommy Thompson said McClellan would not head an HHS task force on drug reimportation as previously planned. -- by Tony Fong
McClellan nomination still mired in controversy
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.